Mycobacterium Citations List: November, 2016

Literature Citations

1. Comparative Analysis of New Peptide Conjugates of Antitubercular Drug Candidates-model Membrane and in Vitro Studies. Abraham, A., Z. Baranyai, G. Gyulai, E. Pari, K. Horvati, S. Bosze, and E. Kiss. Colloids and Surfaces. B, Biointerfaces, 2016. 147: p. 106-115. PMID[27497074].
[PubMed]. TB_11_2016.

2. Evaluation of the Inhibitory Activity of (aza)Isoindolinone-type Compounds: Toward in Vitro InhA Action, Mycobacterium tuberculosis Growth and Mycolic acid Biosynthesis. Chollet, A., J.L. Stigliani, M.R. Pasca, G. Mori, C. Lherbet, P. Constant, A. Quemard, J. Bernadou, G. Pratviel, and V. Bernardes-Genisson. Chemical Biology & Drug Design, 2016. 88(5): p. 740-755. PMID[27301022].
[PubMed]. TB_11_2016.

3. Reynosin and Santamarine: Two Sesquiterpene lactones from Ambrosia confertiflora with Bactericidal Activity against Clinical Strains of Mycobacterium tuberculosis. Coronado-Aceves, E.W., C. Velazquez, R.E. Robles-Zepeda, M. Jimenez-Estrada, J. Hernandez-Martinez, J.C. Galvez-Ruiz, and A. Garibay-Escobar. Pharmaceutical Biology, 2016. 54(11): p. 2623-2628. PMID[27180996].
[PubMed]. TB_11_2016.

4. Identification and Optimization of a New Series of Anti-tubercular Quinazolinones. Couturier, C., C.

Lair, A. Pellet, A. Upton, T. Kaneko, C. Perron, E. Cogo, J. Menegotto, A. Bauer, B. Scheiper, S. Lagrange, and E. Bacque. Bioorganic & Medicinal Chemistry Letters, 2016. 26(21): p. 5290-5299. PMID[27671498].
[PubMed]. TB_11_2016.

5. Bedaquiline (Situro): A Diarylquinoline That Blocks Tuberculosis ATP Synthase for the Treatment of Multi-drug Resistant Tuberculosis. Cruz, E.N., A.N. Moules, and J.J. Li. Innovative Drug Synthesis, 2016: p. 81-97. ISI[000385235300006].

[WOS]. TB_11_2016.

6. Synthesis of Curcumin-loaded Chitosan phosphate Nanoparticle and Study of Its Cytotoxicity and Antimicrobial Activity. Deka, C., L. Aidew, N. Devi, A.K. Buragohain, and D.K. Kakati. Journal of Biomaterials Science. Polymers Edition, 2016. 27(16): p. 1659-1673. PMID[27564239].
[PubMed]. TB_11_2016.

7. FtsZ Inhibition and Redox Modulation with One Chemical Scaffold: Potential Use of Dihydroquinolines against Mycobacteria. Duggirala, S., J.V. Napoleon, R.P. Nankar, V.S. Adeeba, M.K. Manheri, and M. Doble. European Journal of Medicinal Chemistry, 2016. 123: p. 557-567. PMID[27517804].
[PubMed]. TB_11_2016.

8. Synthesis and Biological Activity of Furoxan Derivatives against Mycobacterium tuberculosis. Fernandes, G.F., P.C. de Souza, L.B. Marino, K. Chegaev, S. Guglielmo, L. Lazzarato, R. Fruttero, M.C. Chung, F.R. Pavan, and J.L. Dos Santos. European Journal of Medicinal Chemistry, 2016. 123: p. 523-531. PMID[27508879].
[PubMed]. TB_11_2016.

9. Investigation of C-5 Alkynyl (Alkynyloxy or Hydroxymethyl) and/or N-3 Propynyl Substituted Pyrimidine Nucleoside Analogs as a New Class of Antimicrobial Agents. Garg, S., N. Shakya, N.C. Srivastav, B. Agrawal, D.Y. Kunimoto, and R. Kumar. Bioorganic & Medicinal Chemistry, 2016. 24(21): p. 5521-5533. PMID[27665179].
[PubMed]. TB_11_2016.

10. Synthesis of Some Novel Pyrrolyl Hydrazone Derivatives as an Antitubercular Agents. Joshi, S.D., N. Tigadi, D. Kumar, S.R. Dixit, and N.M. Jangade. Indian Journal of Heterocyclic Chemistry, 2016. 25(3-4): p. 237-241. ISI[000385338500009].

[WOS]. TB_11_2016.

11. Synthesis, Evaluation and Molecular Docking Study of Some New 2-[(2,5-Disubstitutedanilino) phenyl]acetic acid Derivatives. Kerur, S., K. Alagawadi, H.L. Zhu, and F. Manvi. Indian Journal of Pharmaceutical Education and Research, 2016. 50(3): p. 465-471. ISI[000384815600021].

[WOS]. TB_11_2016.

12. Amphiphilic Xanthones as a Potent Chemical Entity of Anti-mycobacterial Agents with Membrane-targeting Properties. Koh, J.J., H. Zou, D. Mukherjee, S. Lin, F. Lim, J.K. Tan, D.Z. Tan, B.L. Stocker, M.S. Timmer, H.M. Corkran, R. Lakshminarayanan, D.T. Tan, D. Cao, R.W. Beuerman, T. Dick, and S. Liu. European Journal of Medicinal Chemistry, 2016. 123: p. 684-703. PMID[27517813].
[PubMed]. TB_11_2016.

13. Bisphosphonic acids as Effective Inhibitors of Mycobacterium tuberculosis Glutamine synthetase. Kosikowska, P., M. Bochno, K. Macegoniuk, G. Forlani, P. Kafarski, and L. Berlicki. Journal of Enzyme Inhibition and Medicinal Chemistry, 2016. 31(6): p. 931-938. PMID[26235917].
[PubMed]. TB_11_2016.

14. Preclinical Comprehensive Physicochemical and Pharmacokinetic Profiling of Novel Nitroimidazole Derivative IIIM-019-A Potential Oral Treatment for Tuberculosis. Kour, G., A. Kumar, P.P. Singh, S. Sharma, A. Bhagat, R.A. Vishwakarma, and Z. Ahmed. Pulmonary Pharmacology & Therapeutics, 2016. 40: p. 44-51. PMID[27457685].

[PubMed].TB_11_2016.

15. Library of Diversely Substituted 2-(Quinolin-4-yl)imidazolines Delivers Novel Non-cytotoxic Antitubercular Leads. Krasavin, M., P. Mujumdar, V. Parchinsky, T. Vinogradova, O. Manicheva, and M. Dogonadze. Journal of Enzyme Inhibition and Medicinal Chemistry, 2016. 31(6): p. 1146-1155. PMID[26526717].

[PubMed].TB_11_2016.

16. Multicomponent Petasis-borono Mannich Preparation of Alkylaminophenols and Antimicrobial Activity Studies. Neto, I., J. Andrade, A.S. Fernandes, C.P. Reis, J.K. Salunke, A. Priimagi, N.R. Candeias, and P. Rijo. ChemMedChem, 2016. 11(18): p. 2015-2023. PMID[27457409].
[PubMed]. TB_11_2016.

17. Anti-tubercular Activities of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-4-amine Analogues Endowed with High Activity toward Non-replicative Mycobacterium tuberculosis. Samala, G., P. Brindha Devi, S. Saxena, S. Gunda, P. Yogeeswari, and D. Sriram. Bioorganic & Medicinal Chemistry, 2016. 24(21): p. 5556-5564. PMID[27667550].
[PubMed]. TB_11_2016.

18. Additional Synthesis on Thiophene-containing Trisubstituted Methanes (TRSMs) as Inhibitors of M. tuberculosis and 3D-QSAR Studies. Singh, P., T. Saha, P. Mishra, M.K. Parai, S. Ireddy, M.S. Lavanya Kumar, S. Krishna, S.K. Kumar, V. Chaturvedi, S. Sinha, M.I. Siddiqi, and G. Panda. SAR and QSAR in Environmental Research, 2016. 27(11): p. 911-937. PMID[27885861].
[PubMed]. TB_11_2016.

19. In Vitro Antimycobacterial and Antimicrobial Activity of Some New Pyrazoline, Isoxazole and Benzodiazepine Derivatives Containing 1,3,5-Triazine Nucleus via Chalcone Series. Solankee, A., R. Tailor, and K. Kapadia. Indian Journal of Chemistry Section B-Organic Chemistry Including Medicinal Chemistry, 2016. 55(10): p. 1277-1287. ISI[000385909600008].

[WOS].TB_11_2016.

20. Et3NH HSO4 Catalyzed Efficient Synthesis of 5-Arylidene-rhodanine Conjugates and Their Antitubercular Activity. Subhedar, D.D., M.H. Shaikh, L. Nawale, A. Yeware, D. Sarkar, and B.B. Shingate. Research on Chemical Intermediates, 2016. 42(8): p. 6607-6626. ISI[000385201400009].

[WOS].TB_11_2016.

21. Antimicrobial Activities of Phosphonium Containing Polynorbornenes. Suer, N.C., C. Demir, N.A. Unubol, O. Yalcin, T. Kocagoz, and T. Eren. RSC Advances, 2016. 6(89): p. 86151-86157. ISI[000384322700057].

[WOS].TB_11_2016.

22. Microwave-assisted Synthesis and Evaluation of Antibacterial Activity of Novel 6-Fluoroaryl-[1,2,4] triazolo[1,5-a]Pyrimidines. Verbitskiy, E.V., S.A. Baskakova, N.A. Rasputin, N.A. Gerasimova, P.G. Amineva, N.P. Evstigneeva, N.V. Zil'berberg, N.V. Kungurov, M.A. Kravchenko, S.N. Skornyakov, G.L. Rusinov, O.N. Chupakhin, and V.N. Charushin. Arkivoc, 2016: p. 268-278. ISI[000385801100018].

[WOS].TB_11_2016.

23. Interactions of Linezolid and Second-line Anti-tuberculosis Agents against Multidrug-resistant Mycobacterium tuberculosis in Vitro and in Vivo. Zhao, W., M. Zheng, B. Wang, X. Mu, P. Li, L. Fu, S. Liu, and Z. Guo. International Journal of Infectious Diseases, 2016. 52: p. 23-28. PMID[27613365].
[PubMed]. TB_11_2016.

Patent Citations

24. Compositions and Methods for Inhibiting Bacterial Growth. Abramovitch, R., B.K. Johnson, and C.J. Colvin. Patent. 2016. 2016-US30689 2016179231: 151pp.

[Patent]. TB_11_2016.

25. Substituted Aminothiazoles for the Treatment of Tuberculosis. Hung, D., M. Serrano-Wu, S. Grant, and T. Kawate. Patent. 2016. 2015-14776521 20160031874.

[Patent]. TB_11_2016.